These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2148155)

  • 1. Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis.
    Reddi AS; Velasco CA; Reddy PR; Khan MY; Camerini-Davalos RA
    Exp Mol Pathol; 1990 Oct; 53(2):140-51. PubMed ID: 2148155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney disease in KK mice: effect of glipizide.
    Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
    [No Abstract]   [Full Text] [Related]  

  • 3. Flavonoid rich fraction of Punica granatum improves early diabetic nephropathy by ameliorating proteinuria and disturbed glucose homeostasis in experimental animals.
    Ankita P; Deepti B; Nilam M
    Pharm Biol; 2015 Jan; 53(1):61-71. PubMed ID: 25289530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme activities as a predictor of diabetic vasculopathy.
    Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
    Am J Med; 1986 Apr; 80(4):574-82. PubMed ID: 2938472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay of progression of diabetic microangiopathy.
    Camerini-Davalos RA; Velasco CA; Reddi AS; Glasser M; Bloodworth JM
    Metabolism; 1988 Feb; 37(2 Suppl 1):10-8. PubMed ID: 2963192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
    Camerini-Davalos RA; Reddi AS; Ehrenreich TH; Strugatz LH; Oppermann W
    Adv Exp Med Biol; 1979; 119():387-400. PubMed ID: 115232
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney disease in KK mice: effect of glyburide.
    Camerini-Davalos RA; Reddi AS
    Adv Exp Med Biol; 1988; 246():297-303. PubMed ID: 2977928
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic microangiopathy in KK mice. V. Effect of early glyburide treatment of kidney glucosyltransferase activity.
    Reddi AS; Oppermann W; Velasco C; Camerini-Davalos RA
    Exp Mol Pathol; 1978 Dec; 29(3):442-7. PubMed ID: 102528
    [No Abstract]   [Full Text] [Related]  

  • 9. An extract of Pueraria tuberosa tubers attenuates diabetic nephropathy by upregulating matrix metalloproteinase-9 expression in the kidney of diabetic rats.
    Tripathi YB; Shukla R; Pandey N; Pandey V; Kumar M
    J Diabetes; 2017 Feb; 9(2):123-132. PubMed ID: 26924185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats.
    Jyothirmayi GN; Alluru I; Reddi AS
    Hypertension; 1996 May; 27(5):1108-14. PubMed ID: 8621204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice.
    Manohar V; Talpur NA; Echard BW; Lieberman S; Preuss HG
    Diabetes Obes Metab; 2002 Jan; 4(1):43-8. PubMed ID: 11874441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4 attenuates early diabetic nephropathy in a mouse model of type 2 diabetes mellitus.
    Zhu J; Su LP; Zhou Y; Ye L; Lee KO; Ma JH
    Am J Ther; 2015; 22(2):141-6. PubMed ID: 23846524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.
    Nakaoka F; Sasakawa Y; Yamamoto K; Nakao M; Nakamura M; Tong C; Fukuhama C; Kagawa K
    Life Sci; 2010 Mar; 86(11-12):424-34. PubMed ID: 20109472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal glucose utilization in genetically diabetic microangiopathy.
    Chen M; Velasco C; Camerini-Davalos RA
    Experientia; 1975 Oct; 31(10):1130-2. PubMed ID: 1204719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic microangiopathy in KK mice. II. Suppression of Glomerulosclerosis by pyridinolcarbamate.
    Reddi AS; Oppermann W; Velasco CA; Camerini-Davalos RA
    Exp Mol Pathol; 1977 Apr; 26(2):325-39. PubMed ID: 852540
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H; Itoh Y; Imamura S; Matsumoto T; Ishiwata Y; Ono Y; Yamamoto K; Kato T; Hayakawa N; Oda N; Goto Y; Goto Y; Nagasaka A; Senda T; Itoh M
    Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metformin treatment on glucose tolerance and glomerulosclerosis in KK mice.
    Reddi AS; Jyothirmayi GN
    Diabete Metab; 1993; 19(1):44-51. PubMed ID: 8504884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice.
    Tahara A; Takasu T
    Eur J Pharmacol; 2018 Jul; 830():68-75. PubMed ID: 29702076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse.
    Lubec B; Aufricht C; Amann G; Kitzmüller E; Höger H
    Nephron; 1997; 75(2):213-8. PubMed ID: 9041544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.